ProShares UltraShort NASDAQ Biotechnology
6 hedge funds and large institutions have $992K invested in ProShares UltraShort NASDAQ Biotechnology in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
6
Holders Change
-2
Holders Change %
-25%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
2
Closed
2
Calls
$4K
Puts
$27K
Net Calls
-$23K
Net Calls Change
-$21K
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$501K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$227K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $501K | 22,364 | +2,043 | +10% |
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $259K | 11,572 | -5,421 | -32% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $227K | 10,125 | +1,846 | +22% |
|
4
Morgan Stanley
New York
| $2.71K | 121 | – | – |
|
5
Citigroup
New York
| $1.91K | 85 | – | – |
|
6
UBS Group
Zurich,
Switzerland
| $134 | 6 | -1,083 | -99% |
|
7
Simplex Trading
Chicago,
Illinois
| – | – | -328 | Closed |
|
8
Osaic Holdings
Scottsdale,
Arizona
| – | – | -50 | Closed |
|
|
CFGS
9
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|